CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Beckman Coulter, Inc. recalls Access Intact PTH assay

Read the official FDA notice

Published
15 Jan 2025
Units affected
362 units
Agency
FDA
Country
United States

The hazard

Beckman Coulter has identified that some Access PTH reagent packs from lot 339071 may be over- or under-filled in well 0. The dispensed material in well 0 could be above or below specification, risking sealing issues, contamination, instrument errors, delays, or inaccurate results with a negative bias and increase in imprecision. The issue was confirmed on 10 April 2024 by Beckman Coulter through an internal non-conformance (NC-INT-66585). The well 0 scale on the filling line began malfunctioning on the fill immediately before PTH. The malfunction was not noticed until the majority of PTH was filled.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

Access Intact PTH assay, a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of intact parathyroid hormone (parathyrin, PTH) levels in human serum and plasma using the Access Immunoassay Systems, Catalog Number A16972

Brand / company
Beckman Coulter, Inc.
Codes / lots
UDI: (01)15099590201937(17)241130(11)231201; Lot 339071
Distribution
Worldwide distribution - US Nationwide and the country of Canada.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 15 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.